Structural Characterisation Reveals Mechanism of IL-13-Neutralising Monoclonal Antibody Tralokinumab as Inhibition of Binding to IL-13Rα1 and IL-13Rα2
Keywords: منطقه تعریف مکمل; IL; interleukin; Th2; T helper type 2; PDB; Protein Data Bank; VH; variable heavy; VL; variable light region; CDR; complementary-determining region; FW; framework; PBS; phosphate-buffered saline; HPLC-SEC; high-performance liquid chromatography-size-exc